Heterosubtypic antibody recognition of the influenza virus hemagglutinin receptor binding site enhanced by avidity

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 42, 2012, Pages 17040-17045

  Lee, Peter S ^a   Yoshida, Reiko ^b   Ekiert, Damian C ^a,d   Sakai, Naoki ^c   Suzuki, Yasuhiko ^b   Takada, Ayato ^b   Wilson, Ian A ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b HOKKAIDO UNIVERSITY   (Japan)

^c UNIVERSITY OF LÜBECK   (Germany)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CROSS REACTING ANTIBODY; IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOGLOBULIN G; INFLUENZA VIRUS HEMAGGLUTININ; NEUTRALIZING ANTIBODY;

ANTIGEN RECOGNITION; ANTIGENIC VARIATION; ANTIVIRAL ACTIVITY; ARTICLE; BINDING AFFINITY; BINDING SITE; COMPLEX FORMATION; CRYSTAL STRUCTURE; INFLUENZA VIRUS; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN PROTEIN INTERACTION; RECEPTOR AFFINITY; RECEPTOR BINDING; VIRUS NEUTRALIZATION; VIRUS PLAQUE; VIRUS STRAIN; VIRUS TYPING;

ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; ANTIBODY AFFINITY; CHROMATOGRAPHY, GEL; CLONING, MOLECULAR; CRYSTALLOGRAPHY, X-RAY; EPITOPES; HEMAGGLUTININS, VIRAL; IMMUNOGLOBULIN FAB FRAGMENTS; INFLUENZA A VIRUS, H3N2 SUBTYPE; INTERFEROMETRY; MODELS, MOLECULAR; NEUTRALIZATION TESTS;

EID: 84867641531     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1212371109     Document Type: Article

References (42)

1. Wilson IA, Skehel JJ, Wiley DC (1981) Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 Å resolution. Nature 289:366-373.
2. Weis W, et al. (1988) Structure of the influenza virus haemagglutinin complexed with its receptor, sialic acid. Nature 333:426-431.
3. Air GM (1981) Sequence relationships among the hemagglutinin genes of 12 subtypes of influenza A virus. Proc Natl Acad Sci USA 78:7639-7643.
4. Nobusawa E, et al. (1991) Comparison of complete amino acid sequences and re-ceptor- binding properties among 13 serotypes of hemagglutinins of influenza A viruses. Virology 182:475- 485.
5. Tong S, et al. (2012) A distinct lineage of influenza A virus from bats. Proc Natl Acad Sci USA 109:4269-4274.
6. Salzberg S (2008) The contents of the syringe. Nature 454:160-161.
7. Wiley DC, Wilson IA, Skehel JJ (1981) Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation. Nature 289:373-378. (Pubitemid 11135143)
8. Caton AJ, Brownlee GG, Yewdell JW, Gerhard W (1982) The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype). Cell 31:417- 427.
9. Ekiert DC, Wilson IA (2012) Broadly neutralizing antibodies against influenza virus and prospects for universal therapies. Curr Opin Virol 2:134-141.
10. Wiley DC, Skehel JJ (1987) The structure and function of the hemagglutinin membrane glycoprotein of influenza virus. Annu Rev Biochem 56:365-394.
11. Skehel JJ, et al. (1982) Changes in the conformation of influenza virus hemagglutinin at the pH optimum of virus-mediated membrane fusion. Proc Natl Acad Sci USA 79:968-972. (Pubitemid 12114045)
12. Bullough PA, Hughson FM, Skehel JJ, Wiley DC (1994) Structure of influenza haemagglutinin at the pH of membrane fusion. Nature 371:37-43. (Pubitemid 24277462)
13. Bizebard T, et al. (1995) Structure of influenza virus haemagglutinin complexed with a neutralizing antibody. Nature 376:92-94.
14. Barbey-Martin C, et al. (2002) An antibody that prevents the hemagglutinin low pH fusogenic transition. Virology 294:70-74. (Pubitemid 34921290)
15. Xu R, et al. (2010) Structural basis of preexisting immunity to the 2009 H1N1 pandemic infl uenza virus. Science 328:357-360.
16. Whittle JR, et al. (2011) Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutinin. Proc Natl Acad Sci USA 108:14216-14221.
17. Ekiert DC, et al. (2009) Antibody recognition of a highly conserved influenza virus epitope. Science 324:246-251.
18. Ekiert DC, et al. (2011) A highly conserved neutralizing epitope on group 2 influenza A viruses. Science 333:843-850.
19. Dreyfus C, et al. (2012) Highly conserved protective epitopes on influenza B viruses. Science 337:1343-1348.
20. Corti D, et al. (2011) A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 infl uenza A hemagglutinins. Science 333:850-856.
21. Kashyap AK, et al. (2008) Combinatorial antibody libraries from survivors of the Turkish H5N1 avian influenza outbreak reveal virus neutralization strategies. Proc Natl Acad Sci USA 105:5986-5991. (Pubitemid 351758386)
22. Throsby M, et al. (2008) Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells. PLoS ONE 3:e3942.
23. Sui J, et al. (2009) Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses. Nat Struct Mol Biol 16:265-273.
24. Kashyap AK, et al. (2010) Protection from the 2009 H1N1 pandemic infl uenza by an antibody from combinatorial survivor-based libraries. PLoS Pathog 6:e1000990.
25. Corti D, et al. (2010) Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine. J Clin Invest 120:1663-1673.
26. Wrammert J, et al. (2011) Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection. J Exp Med 208:181-193.
27. Wei CJ, et al. (2010) Induction of broadly neutralizing H1N1 influenza antibodies by vaccination. Science 329:1060-1064.
28. Treanor JJ, Campbell JD, Zangwill KM, Rowe T,Wolff M(2006) Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine. N Engl J Med 354:1343-1351.
29. Yoshida R, et al. (2009) Cross-protective potential of a novel monoclonal antibody directed against antigenic site B of the hemagglutinin of infl uenza A viruses. PLoS Pathog 5:e1000350.
30. Ohshima N, et al. (2011) Naturally occurring antibodies in humans can neutralize a variety of influenza virus strains, including H3, H1, H2, and H5. J Virol 85:11048-11057.
31. Krause JC, et al. (2011) A broadly neutralizing human monoclonal antibody that recognizes a conserved, novel epitope on the globular head of the influenza H1N1 virus hemagglutinin. J Virol 85:10905-10908.
32. Krause JC, et al. (2011) Epitope-specific human influenza antibody repertoires diversify by B cell intraclonal sequence divergence and interclonal convergence. J Immunol 187:3704-3711.
33. Ekiert DC, et al. (2012) Cross-neutralization of influenza A viruses mediated by a single antibody loop. Nature 489:526-532.
34. Ha Y, Stevens DJ, Skehel JJ, Wiley DC (2003) X-ray structure of the hemagglutinin of a potential H3 avian progenitor of the 1968 Hong Kong pandemic influenza virus. Virology 309:209-218. (Pubitemid 36579216)
35. Fleury D, Wharton SA, Skehel JJ, Knossow M, Bizebard T (1998) Antigen distortion allows influenza virus to escape neutralization. Nat Struct Biol 5:119-123.
36. Fleury D, et al. (1999) A complex of influenza hemagglutinin with a neutralizing antibody that binds outside the virus receptor binding site. Nat Struct Biol 6:530-534. (Pubitemid 29252830)
37. Krause JC, et al. (2012) Human monoclonal antibodies to pandemic 1957 H2N2 and pandemic 1968 H3N2 influenza viruses. J Virol 86:6334-6340.
38. Nabel GJ, Wei CJ, Ledgerwood JE (2011) Vaccinate for the next H2N2 pandemic now. Nature 471:157-158.
39. Harris A, et al. (2006) Influenza virus pleiomorphy characterized by cryoelectron tomography. Proc Natl Acad Sci USA 103:19123-19127. (Pubitemid 350002838)
40. Zhu P, et al. (2006) Distribution and three-dimensional structure of AIDS virus envelope spikes. Nature 441:847-852.
41. Klein JS, et al. (2009) Examination of the contributions of size and avidity to the neutralization mechanisms of the anti-HIV antibodies b12 and 4E10. Proc Natl Acad Sci USA 106:7385-7390.
42. Chen VB, et al. (2010) MolProbity: All-atom structure validation for macromolecular crystallography. Acta Crystallogr D Biol Crystallogr 66:12-21.